Japanese Experts Question mRNA Vaccine Safety at Emergency Press Conference in Japan

Japanese Experts Question mRNA Vaccine Safety at Emergency Press Conference in Japan — fXE1Gwfu
On July 12, 2026, a shocking emergency press conference in Japan revealed disturbing data on mRNA vaccine safety, sparking heated debates on social media and beyond. Comedian and political commentator Jimmy Dore, known for his incisive critiques of the pharmaceutical industry, highlighted the concerns on his X (formerly Twitter) post, which quickly gained traction among the online community. The controversy centers around claims made by Japanese medical professionals, including Professor Dr. Seiji Kojima, a renowned expert in pediatrics and vaccine research, who presented alarming data on the mortality rates among vaccinated individuals. The video clip shared by Jimmy Dore, hosted on aussie17.com, shows a panel discussion at an emergency press conference in Japan, where experts discuss the safety and efficacy of mRNA vaccines. The conference, which took place in 2024 or 2025, was attended by prominent figures, including Professor Dr. Seiji Kojima and Professor Dr. Yasufumi Murakami from Tokyo University of Science. The speakers presented data from various sources, including a bar graph showing all-cause mortality significantly higher in vaccinated groups, with a red arrow noting "5 times" for 2nd dose vs. unvaccinated in elderly. According to the data presented, the mortality rate among vaccinated individuals is five times higher compared to those who are not vaccinated. This alarming statistic has sparked intense debate and raises important questions about the safety and efficacy of mRNA vaccines. The video also touches on the issue of pharmaceutical influence, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy. Dr. Seiji Kojima, a prominent figure in the debate, has a background in pediatrics and has co-authored papers on excess mortality post-COVID vaccination. His work has been referenced in various anti-vaccine circles, and his presentation at the emergency press conference has reignited the conversation on vaccine safety. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines.

Key Facts

The video clip shared by Jimmy Dore shows a panel discussion at an emergency press conference in Japan, where experts discuss the safety and efficacy of mRNA vaccines. The conference, which took place in 2024 or 2025, was attended by prominent figures, including Professor Dr. Seiji Kojima and Professor Dr. Yasufumi Murakami from Tokyo University of Science. The speakers presented data from various sources, including a bar graph showing all-cause mortality significantly higher in vaccinated groups, with a red arrow noting "5 times" for 2nd dose vs. unvaccinated in elderly. According to the data presented, the mortality rate among vaccinated individuals is five times higher compared to those who are not vaccinated. This alarming statistic has sparked intense debate and raises important questions about the safety and efficacy of mRNA vaccines. The video also touches on the issue of pharmaceutical influence, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy.

Background

The controversy surrounding mRNA vaccine safety has been ongoing for several years, with many experts and researchers questioning the efficacy and safety of these vaccines. The emergency press conference in Japan, which took place in 2024 or 2025, brought together prominent figures in the field to discuss the latest data and research on mRNA vaccines. The conference was attended by experts from various institutions, including Tokyo University of Science and Nagoya University. The speakers presented data from various sources, including a bar graph showing all-cause mortality significantly higher in vaccinated groups, with a red arrow noting "5 times" for 2nd dose vs. unvaccinated in elderly. The data presented has sparked intense debate and raises important questions about the safety and efficacy of mRNA vaccines. The video also touches on the issue of pharmaceutical influence, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy.

People Involved

Dr. Seiji Kojima, a prominent figure in the debate, has a background in pediatrics and has co-authored papers on excess mortality post-COVID vaccination. His work has been referenced in various anti-vaccine circles, and his presentation at the emergency press conference has reignited the conversation on vaccine safety. Dr. Kojima's data has sparked intense debate and raises important questions about the safety and efficacy of mRNA vaccines. Professor Dr. Yasufumi Murakami, a colleague of Dr. Kojima's at Tokyo University of Science, also presented data at the emergency press conference. His presentation touched on the issue of pharmaceutical influence, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy.

Reactions

The video clip shared by Jimmy Dore has sparked intense debate on social media, with many users sharing their reactions and opinions on the safety and efficacy of mRNA vaccines. The controversy has also reignited the conversation on vaccine safety, with many experts and researchers weighing in on the issue. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines. The video also touches on the issue of pharmaceutical influence, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy.

Implications

The controversy surrounding mRNA vaccine safety has significant implications for public health policy and the pharmaceutical industry. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines. The issue of pharmaceutical influence is also a major concern, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy. The controversy has also reignited the conversation on vaccine safety, with many experts and researchers weighing in on the issue.

What Happens Next

The controversy surrounding mRNA vaccine safety is ongoing, with many experts and researchers continuing to weigh in on the issue. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines. The issue of pharmaceutical influence is also a major concern, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy. The controversy has also reignited the conversation on vaccine safety, with many experts and researchers weighing in on the issue.
Japanese Experts Question mRNA Vaccine Safety at Emergency Press Conference in Japan — 2I vGEQ1
Japanese Experts Question mRNA Vaccine Safety at Emergency Press Conference in Japan — HM9Lkr1bMAAB1tr

For more on this, see MjtgatSVSJtA10vZ.

For more on this, see video.twimg.com.

For more on this, see 196275 increased age adjusted cancer mortality after the third mrna lipid nanoparticle vaccine dose during the covid 19 pandemic in japan.

For more on this, see 0EvFPCAWq7.

For more on this, see vU0FN5Npky.

For more on this, see 196275.

For more on this, see Jimmy Dore.

Frequently Asked Questions

What is the controversy surrounding mRNA vaccine safety?
The controversy surrounds claims made by Japanese medical professionals, including Professor Dr. Seiji Kojima, who presented alarming data on the mortality rates among vaccinated individuals. According to the data presented, the mortality rate among vaccinated individuals is five times higher compared to those who are not vaccinated.
What is the significance of the emergency press conference in Japan?
The emergency press conference brought together prominent figures in the field to discuss the latest data and research on mRNA vaccines. The conference was attended by experts from various institutions, including Tokyo University of Science and Nagoya University.
Who are the key figures involved in the controversy?
Dr. Seiji Kojima, a prominent figure in the debate, has a background in pediatrics and has co-authored papers on excess mortality post-COVID vaccination. Professor Dr. Yasufumi Murakami, a colleague of Dr. Kojima's at Tokyo University of Science, also presented data at the emergency press conference.
What are the implications of the controversy for public health policy?
The controversy has significant implications for public health policy, with many experts and researchers calling for further investigation into the safety and efficacy of mRNA vaccines. The issue of pharmaceutical influence is also a major concern, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy.
What happens next in the controversy surrounding mRNA vaccine safety?
The controversy is ongoing, with many experts and researchers continuing to weigh in on the issue. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines.

Conclusion

The controversy surrounding mRNA vaccine safety is a complex and multifaceted issue, with significant implications for public health policy and the pharmaceutical industry. The data presented by Dr. Kojima and other experts has sparked intense debate, with many calling for further investigation into the safety and efficacy of mRNA vaccines. The issue of pharmaceutical influence is also a major concern, with speakers criticizing the industry's control over the narrative and its potential impact on public health policy. The controversy has also reignited the conversation on vaccine safety, with many experts and researchers weighing in on the issue. As the debate continues, it is essential to consider the potential consequences of mRNA vaccines on public health and the pharmaceutical industry. The data presented by Dr. Kojima and other experts has sparked a necessary conversation, and it is crucial to continue investigating the safety and efficacy of these vaccines. The emergency press conference in Japan has brought attention to the controversy surrounding mRNA vaccine safety, and it is essential to continue the discussion on this critical issue. The implications of the controversy are far-reaching, and it is crucial to consider the potential consequences for public health policy and the pharmaceutical industry. In conclusion, the controversy surrounding mRNA vaccine safety is a complex and multifaceted issue, with significant implications for public health policy and the pharmaceutical industry. The data presented by Dr. Kojima and other experts has sparked intense debate, and it is essential to continue investigating the safety and efficacy of mRNA vaccines.